OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GALT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Galectin Therapeutics (GALT) Earnings Date & Reports

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GALT is expected to report earnings to rise 50.00% to -18 cents per share on November 17

Galectin Therapeutics GALT Stock Earnings Reports

Q3'25

Est.

$-0.18

Q2'25

Beat

by $0.07

Q1'25

Beat

by $0.05

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.02

The last earnings report on August 14 showed earnings per share of -11 cents, beating the estimate of -18 cents. With 71.75K shares outstanding, the current market capitalization sits at 272.26M.

View a ticker or compare two or three

Compare

GALT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GALT
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GALT showed earnings on August 14, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of drugs to combat various diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

4960 Peachtree Industrial Boulevard

Phone

+1 678 620-3186

Employees

Web

https://www.galectintherapeutics.com